Ionis Pharmaceuticals, Inc. (LON:0JDI)
73.14
+0.64 (0.88%)
At close: Oct 17, 2025
Ionis Pharmaceuticals Revenue
Ionis Pharmaceuticals had revenue of $452.05 million USD in the quarter ending June 30, 2025, with 100.69% growth. This brings the company's revenue in the last twelve months to $944.05 million, up 16.05% year-over-year. In the year 2024, Ionis Pharmaceuticals had annual revenue of $705.14 million, down -10.48%.
Revenue (ttm)
$944.05M
Revenue Growth
+16.05%
P/S Ratio
12.62
Revenue / Employee
$883.12K
Employees
1,069
Market Cap
8.70B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 705.14M | -82.51M | -10.48% |
Dec 31, 2023 | 787.65M | 200.28M | 34.10% |
Dec 31, 2022 | 587.37M | -223.09M | -27.53% |
Dec 31, 2021 | 810.46M | 81.19M | 11.13% |
Dec 31, 2020 | 729.26M | -393.34M | -35.04% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
Hikma Pharmaceuticals | 2.35B |
ConvaTec Group | 1.72B |
Spire Healthcare Group | 1.55B |
Genus | 672.80M |
Ionis Pharmaceuticals News
- 3 days ago - Insider Sell Alert: B Parshall Sells 5,000 Shares of Ionis Pharmaceuticals Inc (IONS) - GuruFocus
- 3 days ago - Morgan Stanley Raises Price Target for Ionis Pharmaceuticals (IONS) | IONS Stock News - GuruFocus
- 3 days ago - Ionis to hold third quarter 2025 financial results webcast - Business Wire
- 11 days ago - Insider Sell: Brett Monia Sells Shares of Ionis Pharmaceuticals Inc (IONS) - GuruFocus
- 11 days ago - Ionis Pharmaceuticals, Inc. (IONS) Shareholder/Analyst Call - Slideshow - Seeking Alpha
- 11 days ago - Needham Raises Price Target on Ionis Pharmaceuticals (IONS) to $78 | IONS Stock News - GuruFocus
- 11 days ago - Oppenheimer Raises Ionis Pharmaceuticals (IONS) Price Target to $90 | IONS Stock News - GuruFocus
- 11 days ago - JP Morgan Boosts Ionis Pharmaceuticals (IONS) with Upgrade and Price Target Increase - GuruFocus